Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of ombitasvir/paritaprevir/ritonavir with dasabuvir and ribavirin in adults with genotype 1 and genotype 4 chro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis
• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ombitasvir (ombitasvir)
• Paritaprevir (paritaprevir)
• Ribavirin (ribavirin)
• Ritonavir (Ritonavir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C, Decompensated Cirrhosis | Phase 3 | Status: COMPLETED | Results posted: 2017-07-11